All In Biotech

Drug Trial Radar · NCT00878709

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

A Randomized, Double-Blind, Placebo-Controlled Trial Of Neratinib (HKI-272) After Trastuzumab In Women With Early-Stage HER-2/Neu Overexpressed/Amplified Breast Cancer

Last checked: Nov 20, 2026Latest source record: Jun 11, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 2,840 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

2,840

Actual

Start

Jul 9, 2009

Primary completion

Aug 21, 2014

Study completion Oct 4, 2019

Sponsor

Lead sponsor
Puma Biotechnology, Inc.Industry
Sponsor type
Industry
First posted
Apr 9, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to investigate whether neratinib can further reduce the risk of recurrence from previously diagnosed HER-2 positive breast cancer after adjuvant treatment with trastuzumab.

Conditions

  • Breast Cancer

Interventions

  • neratinibDrug

  • placeboOther

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Invasive Disease-free Survival (iDFS) in Neratinib Arm Compared to Placebo Arm at Year 2Time frame: From randomization until time of event up to 2 years
  2. Kaplan-Meier Estimates of Invasive Disease-free Survival (iDFS) at Year 2 by Treatment ArmsTime frame: From randomization until time of event up to 2 years

Locations

494 sites in 40 countries. Site status is shown where the registry gives one.

  • Anniston Oncology

    Anniston, Alabama

  • Birmingham Hematology and Oncology Associates, LLC

    Birmingham, Alabama

  • Arizona Oncology Associates, PC - HAL

    Phoenix, Arizona

  • Arizona Oncology Associates, PC - NAHOA

    Sedona, Arizona

  • Arizona Oncology Associates

    Tucson, Arizona

  • Arizona Cancer Center

    Tucson, Arizona

  • Northeast Arkansas Clinic

    Jonesboro, Arkansas

  • Cedars-Sinai Medical Group

    Beverly Hills, California

  • Ronald Yanagihara, M.D.

    Gilroy, California

  • Glendale Adventist Medical Center Cancer Services

    Glendale, California

  • California Cancer Care

    Greenbrae, California

  • Beaver Medical Group, L.P.

    Highland, California

  • Breastlink Medical Group

    Long Beach, California

  • Long Beach Memorial Medical Center

    Long Beach, California

  • Facey Medical Group

    Mission Hills, California

  • Gynecologic Oncology Associates

    Newport Beach, California

  • Ventura County Hematology-Oncology Specialists

    Oxnard, California

  • Desert Hematology Oncology Medical Group, Inc

    Rancho Mirage, California

  • Helen Diller Family University of California San Francisco Comprehensive Cancer Center

    San Francisco, California

  • San Francisco Oncology Associates

    San Francisco, California

  • Redwood Regional Medical Group

    Santa Rosa, California

  • The Cancer Prevention and Treatment Center

    Soquel, California

  • Cancer Center of Central Connecticut

    Southington, Connecticut

  • Hematology Oncology, PC

    Stamford, Connecticut

  • Connecticut Oncology and Hematology

    Torrington, Connecticut

  • Washington Cancer Institute at Washington Hospital Center

    Washington D.C., District of Columbia

  • Innovative Medical Research of South Florida, Inc.

    Aventura, Florida

  • University Cancer Institute, LLC

    Boynton Beach, Florida

  • North Broward Medical Center

    Deerfield Beach, Florida

  • Broward General Medical Center

    Fort Lauderdale, Florida

  • Florida Cancer Specialists and Research Institute

    Gainesville, Florida

  • Lakeland Regional Cancer Center

    Lakeland, Florida

  • Hematology Oncology Associates

    Loxahatchee Groves, Florida

  • Florida Cancer Affiliates - Ocala

    Ocala, Florida

  • Mid-Florida Hematology & Oncology Centers, PA

    Orange City, Florida

  • Cancer Centers of Florida

    Orlando, Florida

  • M.D. Anderson Cancer Center Orlando

    Orlando, Florida

  • Florida Cancer Research Institute

    Plantation, Florida

  • Hematology Oncology Associates of Treasure Coast

    Port Saint Lucie, Florida

  • Florida Cancer Specialists, P.L.

    St. Petersburg, Florida

Showing 40 of 494 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.